![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 11, 6367-6372, March 13, 1998
From the Institut de Génétique et Microbiologie,
Université Paris-Sud, URA CNRS D 2225, Centre Universitaire
d'Orsay, Bâtiment 409, F-91405 Orsay Cedex, France
Carbon catabolite repression is mediated in
Aspergillus nidulans by the negative acting protein CreA.
The CreA repressor plays a major role in the control of the expression
of the alc regulon, encoding proteins required for the
ethanol utilization pathway. It represses directly, at the
transcriptional level, the specific transacting gene alcR,
the two structural genes alcA and aldA, and
other alc genes in all physiological growth conditions.
Among the seven putative CreA sites identified in the alcA
promoter region, we have determined the CreA functional targets in AlcR constitutive and derepressed genetic backgrounds. Two different divergent CreA sites, of which one overlaps a functional AlcR inverted
repeat site, are largely responsible for alcA repression. Totally derepressed alcA expression is achieved when these
two CreA sites are disrupted in addition to another single site, which overlaps the functional palindromic induction target. The fact that
derepression is always associated with alcA overexpression is consistent with a competition model between AlcR and CreA for their
cognate targets in the same region of the alcA
promoter.
Our results also indicate that the CreA repressor is necessary and
sufficient for the total repression of the alcA gene.
Aspergillus nidulans is a versatile organism capable of
growing on a wide variety of nutrients by expressing enzymes and
permeases involved in specific utilization pathways. When ethanol or a
related carbon source is added to a growing culture of the fungus
A. nidulans, the alc genes are expressed. They
comprise not only the genes necessary for ethanol degradation, namely
alcA and aldA, encoding alcohol dehydrogenase I
(ADHI)1 and aldehyde
dehydrogenase, respectively (1, 2), but at least four other
alc genes (alcO, -M, -S,
and -U), recently identified (3), which are clustered in the
same locus in chromosome VII, as are alcA and
alcR. This latter gene encodes the specific transactivator of the ethanol utilization pathway, AlcR, a zinc binuclear cluster protein of the C6 class, with features that differentiate it from the
other proteins of this class (4, 5). The AlcR protein is able to bind
in vitro to specific DNA single sites occurring as either
direct or inverted repeats (6, 7). An interesting aspect of AlcR
activity is that in vivo, only repeated sites mediate specific transcriptional induction (6, 8). The alcR gene itself is subjected to a positive feedback control (9) via the binding
of the AlcR protein to targets in the alcR promoter (6). The
strong inducible alcA promoter encompasses three clustered AlcR targets (10), which are responsible for the synergistic activation
of the alcA gene (8).
When a favored carbon source such as glucose is added to the culture
medium, transcription of the alc regulon is severely reduced
(11). This phenomenon is mediated by CreA, the repressor responsible
for carbon catabolite repression in A. nidulans (12). CreA
contains two Cys2-His2 fingers and is related
to MIG1, the repressor responsible for glucose repression of several
genes in Saccharomyces cerevisiae, and to the mammalian
Krox20/Egr and Wilm's tumor proteins (13). CreA counterparts have also
been found in other fungal species such as Aspergillus niger
and Trichoderma reesei (14, 15). All of these proteins bind
to a GC-rich motif. Binding sites for CreA, whose consensus sequence is
5'-(C/G)YGGRG-3', have been identified in the alc regulon
(11, 16, 17) and in the proline cluster (18). The repressor CreA exerts
transcriptional repression on the trans-acting gene
alcR and independently on structural genes alcA
and aldA (17). A great number of CreA binding sites have
been identified in the upstream regions of the alcR and
alcA genes, and these sites are localized in the same region
as the specific AlcR binding sites (16). In the alcR
promoter region, it has been shown that for at least one of the CreA
binding sites overlapping the AlcR inverted repeat target, direct
competition between the two regulators occurs both in vitro
and in vivo. More generally, under nonrepressing
physiological growth conditions (induced and noninduced), it was shown
that both regulators control the expression of the alc genes
(19, 20). The interplay between these two circuits therefore regulates the expression of the ethanol regulon genes.
In the alcA promoter, several CreA binding sites have been
identified by sequence analysis. Three are close to or overlap AlcR
binding sites. The alcA promoter is one of the strongest inducible genes in A. nidulans. Synergistic transcriptional
activation by AlcR is mediated by three sets of AlcR repeat sites,
which were shown to be functional in vivo and represent
alc upstream activating sequences (8). The transcriptional
induction of the alcA gene is absolutely dependent upon the
presence of AlcR. In glucose-repressed conditions, the alcR
gene is totally repressed, and as a consequence (by a cascade
mechanism), alcA is not expressed (9).
The aim of this work was to understand the mechanism of carbon
catabolite repression in the alcA promoter. We have
addressed several questions: (i) which CreA binding sites are
functional in vivo; (ii) whether CreA is the only repressor
responsible for alcA glucose repression; and (iii) whether
there is competition between the activator AlcR and the repressor CreA
for the same region in the alcA promoter in A. nidulans.
Strains, Media, and Growth Conditions--
The A. nidulans strain used as the host for transformation was
alcA Plasmid Construction and Transformant Selection--
The
constitutive and derepressed pgpdA:alcR:argB plasmid (bAN8)
was constructed as follows. The alcR coding sequence was
amplified by polymerase chain reaction from the
SalI-SalI (
The CreA Repressor Is the Sole DNA-binding Protein Responsible
for Carbon Catabolite Repression of the alcA Gene in
Aspergillus nidulans via Its Binding to a Couple of
Specific Sites*
,
![]()
ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References
![]()
EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References
argB
uaZ
(alcA4951,
argB2, pabaA1, yA2, uaZ11).
Media and supplements were as described by Cove (21). The mycelia for
Northern analyses and ADHI activities were grown for 7 h at
37 °C on 0.1% fructose as the sole carbon source. Induction was
achieved by adding the gratuitous inducer ethyl methyl ketone (50 mM) or ethanol (50 mM). Cells were harvested
after a further 2.5 h (induced conditions). Under repressed
conditions, 1% glucose was added simultaneously with the inducer.
1064 to +2848) fragment of the
alcR gene, introducing an EcoRI site at the
5'-end and an NcoI site at the ATG. The
EcoRI-SalI (
5 to +2848) fragment was cloned
into the EcoRI-SalI sites of pBluescript SK+,
resulting in plasmid bAN6. The EcoRI-NcoI
fragment corresponding to the gpdA promoter was cloned into
the EcoRI-NcoI sites of bAN6, resulting in bAN7.
The XbaI-XbaI fragment (made blunt end), of the
argB gene was cloned into the EcoRI site (made
blunt end) of plasmid bAN7, resulting in plasmid bAN8.
argB
uaZ
strain was transformed with bAN8 or bAN10. Southern blot analysis of
the selected argB+ transformants showed that the plasmids
were integrated at the argB locus (data not shown).
A plasmid deleted for the CreA binding sites C, D1,
D2, and E was obtained by deleting the
HindIII-PvuII (
738 to
423) fragment from
plasmid bAuaZ, which contains the alcA gene
(HindIII-KpnI (
738 to
2024) fragment) and
the 3' ClaI-XhoI fragment of the uaZ
gene able to complement by site-directed integration the
uaZ11 translocation, resulting in plasmid bAN50.
Disruption of CreA binding sites (A, B1, and
B2) was achieved by site-directed mutagenesis carried out
by the method of Kunkel et al. (22). A uracil-SK template
(bANC), containing the alcA promoter from the
MluI (
255) to ApaI (+19) sites, was
mutagenized. Mutations in CreA sites A, B1, B2,
B1B2, and AB1B2
(single, double, and triple mutations) were confirmed by sequencing.
Cloning of these mutated sequences was achieved by substituting the
ApaI-ApaI or the
MluI-ApaI fragments of bAN50 with the
corresponding mutated sequences, resulting in plasmids pUA (A mutated),
pUB1 (B1 mutated), pUB2
(B2 mutated), pUB1B2
(B1B2 mutated), and
pUAB1B2 (AB1B2
mutated).
All of the plasmids were used to transform the gpdA:alcR
(Tg) strain, resulting in the TgmA strain transformed by pUA, the TgmB1 strain transformed by pUB1, the
TgmB2 strain transformed by pUB2, the
TgmB1B2 strain transformed by
pUB1B2, the TgmAB1B2 strain transformed by pUAB1B2, and the
Tg
CD1D2E strain transformed by bAN50. The
pUB1B2 and pUAB1B2 were
also used to transform the argB:pyrG:alcR (Tp) strain,
resulting, respectively, in TpmB1B2 and
TpmAB1B2 transformant strains.
Southern blot analysis of the selected uaZ+
transformants showed that the plasmids were integrated in a single copy
at the uaZ locus (data not shown).
Isolation of RNA and Quantitative Analyses-- Total RNA was isolated from A. nidulans as described by Lockington et al. (23), separated on agarose gels after denaturation by glyoxal (24) and blotted on Hybond-N membranes (Amersham Corp.). Hybridization was carried out in 0.5 M sodium orthophosphate, pH 7, 1 mM EDTA, 7% SDS, and 1% bovine serum albumin at 65 °C for at least 14 h. The probes used were the entire genes either of alcR or alcA, cloned into Bluescript plasmids (1, 25) and labeled with [32P]dCTP using random hexanucleotide primers (Amersham). The membranes were also hybridized with a BamHI-KpnI restriction fragment containing the actin gene, isolated from the pSF5 plasmid (26), as an internal control to monitor the amount of mRNA loaded. Autoradiograms were developed at various times to avoid saturation of the film. Densitometric scanning was performed with a system Biosoft-Orkis. Experiments were repeated at least three times. The amount of specific mRNA was calculated relative to the actin signal. Observed variations among the various hybridizations were 20-30%.
Polyacrylamide Gel Electrophoresis and ADHI Activity-- Gel electrophoresis and activity staining of ADHI were carried out according to the method described by Sealy-Lewis and Fairhurst (27). Protein concentration was measured according to Bradford (28). Concentrations of protein from different extracts were equalized before loading onto a gel and verified by Coomassie staining. Densitometric scanning was performed. Variations of 20-30% were observed between experiments.
| |
RESULTS |
|---|
|
|
|---|
Identification of CreA Binding Sites in the alcA Promoter-- Fig. 1 shows that seven CreA binding sites are localized in the alcA promoter. Two of them, A and B1, have been identified by footprint analysis (16), and the others, B2, C, D1, D2, and E, have been identified by sequence analysis through searching for the same consensus motif, 5'-(G/C)YGGRG-3'. We have shown previously that in vitro CreA is able to bind to any of these sites even when the flanking DNA sequence is completely unrelated to A. nidulans, such as the polylinker region of a Bluescript plasmid (16). This was confirmed by in vitro analysis of CreA binding to the penicillin biosynthetic gene in A. nidulans, which is not subject to CreA control in vivo (29) and was also suggested by Cubero and Scazzocchio (18) with the prn cluster. The same conclusions were drawn after in vitro localization of MIG1 binding sites, the repressor responsible for glucose-repressed genes in S. cerevisiae (30).
|
alcA Expression Is Dependent upon the Level of the AlcR Protein-- The analysis of the mechanism of carbon catabolite repression of the alcA promoter has to be performed in an alcR-derepressed background. The reason already mentioned is the absolute dependence for alcA transcription on the presence of an active AlcR protein that is repressed in glucose growth medium. A constitutively derepressed alcR strain was constructed using the promoter of gpdA, encoding glyceraldehyde-3-phosphate dehydrogenase, upstream of the full-length alcR gene with its own transcriptional termination signal, unlike our previous construct in which the first six amino residues and the termination signal of AlcR were deleted (4, 17).
The gpdA promoter is very strong and drives the expression of a high amount of alcR gene. Under repressing growth conditions, alcA transcription is substantially derepressed (50%) as a consequence of AlcR synthesis. Since the level of alcA expression is dependent on that of alcR (17), it was important to set up glucose-repressing conditions in which alcA expression could be monitored with suitable accuracy. It has been shown previously (31) that total alcohol dehydrogenase activity in crude extracts varies considerably, depending upon the alcohols and ketones used as inducers. The best inducer was shown to be the gratuitous inducer butan-2-one (also called ethyl methyl ketone (EMK)). Transcriptional analyses of alcR and alcA and semiquantitative measurements of ADHI activity, estimated by specific staining of gels after native electrophoresis, of the gpdA:alcR strain were compared with the wild type strain after the addition of two different external inducers, ethyl methyl ketone and ethanol. Northern blots, presented in Fig. 2A, show that both these external inducers have about the same transcriptional inducing ability for alcR in the wild type strain and in the gpdA:alcR strain, in which a higher steady state amount of alcR mRNA is also observed. As a result, an increase in alcA transcription is observed in the gpdA:alcR strain compared with the wild type strain, which, in the presence of the inducer ethanol, is 4-fold higher and in the presence of EMK is 8-fold higher.
|
Among Seven CreA Binding Sites, a Pair of Sites Is Largely
Responsible for alcA Repression--
As seen in Fig. 1, seven putative
CreA binding sites, sharing the consensus sequence, 5'-(C/G)YGGRG-3',
have been identified in the alcA promoter. Four of them, C,
D1, D2, and E, localized in the 5'
alcA promoter region, have been deleted. The resulting deleted alcA plasmid, containing the selectable
uaZ gene marker, was used to transform the A. nidulans
gpdA:alcR alcA
uaZ
strain.
Transformants containing a single copy of the alcA gene, integrated in the uaZ locus, were selected. ADHI activity of
the selected transformants (TA
CD1D2E) was
estimated by native gel staining after noninduced, induced, and
glucose-repressed conditions and compared with the control strain
carrying the entire alcA gene in the gpdA:alcR
background. Similar ADHI activities were obtained in all growth
conditions (results not shown). Therefore, we can conclude that CreA
binding sites C, D1, D2, and E do not contribute to alcA repression.
|
alcA Derepression following CreA Binding Site Disruption Is Independent of AlcR Level-- To know if alcA expression could be totally derepressed, the three active CreA binding sites A, B1, and B2 were disrupted. All mutagenized alcA transformants were selected as single copy integrants at the uaZ locus.
Interestingly, analysis of transformants in which B1 and B2 CreA binding sites are simultaneously mutagenized results in the same increase in induction and the same level of derepression as observed after the disruption of either B1 or B2 CreA binding sites (Fig. 4). Therefore, it seems that CreA sites B1 and B2 are working as a pair. When the three CreA binding sites A, B1, and B2 are disrupted simultaneously, as in Tgm(AB1B2), it is clear that there is a large increase in induced ADHI activity besides an almost totally derepressed ADHI activity (Fig. 4). To verify that this total derepression did not result from the high AlcR concentration driven by the strong gpdA promoter, AlcR was expressed under the control of the pyrG promoter (pyrG encodes orotidine-5'-phosphate decarboxylase). This promoter is not subject to carbon catabolite repression and is considered as a weak, noninducible promoter. A translational fusion between the pyrG promoter and the alcR coding sequence was constructed, and the argB auxotrophy gene was also inserted into the plasmid. A selected argB+ transformant, containing pyrG:alcR, was then used as the recipient strain (TpyrG alcA
uaZ
) for plasmids
carrying the mutagenized alcA gene. This strain contains the
pyrG:alcR gene in addition to the alcR resident
gene.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
We have previously shown that the repressor CreA, responsible for carbon catabolite repression in A. nidulans, acts at two different levels. First, it prevents completely the transcription of the trans-acting gene alcR, which could account for the drastic decrease of transcription of the two structural genes alcA and aldA (9) and also of the other clustered alc genes (3). Second, however, direct repression of the two structural genes alcA and aldA (17) and of other alc genes such as alcS and alcO (3) also occurs via the CreA binding sites localized in the promoter regions of these genes. This was shown in a partially derepressed alcR context, obtained either by mutagenesis of one CreA binding site in the alcR promoter or by driving alcR transcription from a constitutive (and derepressed) promoter (17). Results shown here demonstrate that among seven CreA binding sites identified in the alcA promoter, two sites (B1 and B2) are largely responsible for alcA repression, with site A making a minor contribution. These three functional CreA targets have completely different flanking regions (as seen in Fig. 1), and no AT-rich region is found. The importance of a flanking AT-rich region in site recognition by MIG1 was shown by Lundin et al. (30). Since the mode of recognition of MIG1 and CreA are similar, a similar role for the flanking regions may also have been expected. In vitro binding of CreA to sites in the ipnA promoter region is AT context-dependent (29). Functional CreA targets in the alcR promoter (17) and in the prnB promoter (18) show AT-rich regions upstream from the GC consensus sequence. However, it has to be pointed out that in some physiological CreA target, as in the alcR promoter,2 and in known MIG1 sites (in GAL1 and GAL4) involved in glucose repression, no AT-rich flanking sequence have been found. In the ipnA promoter, the in vitro CreA binding sites are not functional in vivo (29). We have to mention that in vitro CreA binding sites have been localized using a dimeric GST-CreA fusion protein. We have recently shown in our laboratory (7) that the utilization of GST, as an AlcR GST fusion protein, can introduce a serious bias in AlcR DNA recognition of AlcR sites in the alcR, alcA, and aldA promoters, probably as a consequence of the normally monomeric structure of AlcR. It is also expected that CreA is monomeric in solution, as demonstrated for the related Zif268 protein by crystallography studies. It is therefore possible that the use of a GST-CreA fusion protein will also introduce DNA recognition artifacts. It was postulated by Espeso and Peñalva (29) and by Cubero and Scazzocchio (18) that the dimeric nature of GST:CreA fusions could stabilize CreA binding to sites that do not fit the GC consensus site. In this regard, physiological results should also be used when defining CreA targets. Therefore, CreA targets in the alcA promoter, localized in vivo by site-directed mutagenesis, can be considered as upstream repressing sequences.
Interestingly, functional CreA binding sites are more often organized as pairs of sites directly repeated (e.g. the alcR promoter (16))2 or as inverted repeats (e.g. the alcA promoter (this work) and in the prnB promoter region (18)). The single CreA A site in the alcA promoter makes only a minor contribution to glucose repression. MIG1 sites are also often organized as repeats (e.g. the promoters of GAL1, SUC2 (32)). It is well established that MIG1 recruits TUP1 and SSN6, which are general repressors, to establish repression of glucose-repressed promoters. It is possible that CreA acts in a similar way to repress the transcriptional machinery and that two CreA binding sites are necessary.
Disruption of the three CreA targets, B1, B2, and A, results in totally derepressed alcA gene expression. This result indicates that CreA seems to be the only repressor acting directly on alcA during carbon catabolite repression. In S. cerevisiae, it has been shown recently that besides MIG1, another similar zinc finger repressor MIG2, which binds to the same binding sites as MIG1, is involved in glucose repression of SUC2 expression (33). In fact, disruption of MIG1 relieves most of the glucose repression of GAL1 and GAL4 expression, partially relieves SUC2 repression, and has no effect on the glucose repression of other genes (34). In A. nidulans, no carbon catabolite repressor, other than CreA, has been found. This is in agreement with our results presented here and with the complete glucose-derepressed prnB expression observed after the disruption of two CreA binding sites.3 In this system, it was shown recently that CreA binding prevents the activity of a positive element on the prnB promoter (35).
In the alcA promoter, CreA sites are very close to, and even overlap with, the AlcR binding sites. It is noticeable that there is a correlation between the level of alcA derepression and that of overexpression. In agreement with our previous results (17, 19), this correlation also indicates that CreA is active under derepressing conditions. The disruption of the minor CreA A site results in a weak increase in alcA expression, whereas disruption of the pair sites, B1 and B2, playing the major role in repression, results in a drastic increase in alcA expression. The alcA promoter region encompassing the induction target c comprises direct repeats (c1-c2) and an overlapping inverted repeat (c3) separated by 16 base pairs with respect to c2. It was recently shown that to reach full alcA transcriptional activation, the three sites, c1, c2, and c3, are necessary (8). The CreA B1 site overlaps the AlcR c3 site, and the CreA B2 site is localized only 17 nucleotides downstream from B1. The size of the AlcR protein is 92 kDa, and that of CreA is 47 kDa. It is possible, therefore, to imagine a steric hindrance between AlcR and CreA for their cognate targets localized in the same region of the alcA promoter. This steric competition could account for alcA overexpression when functional CreA binding sites are disrupted. The induction of alcA is correlated with the level of AlcR, as observed in contexts in which AlcR is highly (gpdA:alcR) or moderately (pyrG:alcR) expressed. Interestingly, when the functional CreA targets are disrupted in the alcA promoter, the level of derepression is independent of AlcR. This result is expected, since in the absence of CreA sites, AlcR can fully occupy its cognate targets. In the alcR promoter, which is positively autoregulated, the induction site overlaps a CreA site. Disruption of this CreA site results in an overexpression of alcR and only a partial derepression, since other CreA sites should be functional in the alcR promoter. The mechanism involved is a direct competition between the two regulators AlcR and CreA (17). Such a competition mechanism could control the expression of other clustered alc genes, such as alcS and alcO, where promoter regions contain both AlcR and CreA sites (20). These results are in agreement with a regulatory mechanism whereby the relative levels of these proteins govern the degree of alc regulon expression under different growth conditions.
| |
ACKNOWLEDGEMENT |
|---|
We thank David Clarke for editorial corrections to the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by grants from CNRS (URA D2225), from the University Paris-Sud XI, and from the European Community (contracts BIO2-CT93-0174 and BIO4-CT96-0535).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a doctoral fellowship from the European Community
(BIO4-CT96-5071).
§ To whom correspondence should be addressed. Tel.: 33 1 69 15 63 28; Fax: 33 1 69 15 78 08; E-mail: felenbok{at}igmors.u-psud.fr.
1 The abbreviations used are: ADHI, alcohol dehydrogenase I; EMK, ethyl methyl ketone.
2 M. Mathieu and B. Felenbok, unpublished results.
3 V. Gavrias and C. Scazzocchio, personal communication.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Jiang, H. Ouyang, H. Zhou, and C. Jin GDP-mannose pyrophosphorylase is essential for cell wall integrity, morphogenesis and viability of Aspergillus fumigatus Microbiology, September 1, 2008; 154(9): 2730 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MacPherson, M. Larochelle, and B. Turcotte A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 583 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rauscher, E. Wurleitner, C. Wacenovsky, N. Aro, A. R. Stricker, S. Zeilinger, C. P. Kubicek, M. Penttila, and R. L. Mach Transcriptional Regulation of xyn1, Encoding Xylanase I, in Hypocrea jecorina Eukaryot. Cell, March 1, 2006; 5(3): 447 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Boase, R. A. Lockington, J. R. J. Adams, L. Rodbourn, and J. M. Kelly Molecular Characterization and Analysis of the acrB Gene of Aspergillus nidulans: A Gene Identified by Genetic Interaction As a Component of the Regulatory Network That Includes the CreB Deubiquitination Enzyme Genetics, May 1, 2003; 164(1): 95 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flipphi, P. J. I. van de Vondervoort, G. J. G. Ruijter, J. Visser, H. N. Arst Jr., and B. Felenbok Onset of Carbon Catabolite Repression in Aspergillus nidulans. PARALLEL INVOLVEMENT OF HEXOKINASE AND GLUCOKINASE IN SUGAR SIGNALING J. Biol. Chem., March 28, 2003; 278(14): 11849 - 11857. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. de Vries and J. Visser Aspergillus Enzymes Involved in Degradation of Plant Cell Wall Polysaccharides Microbiol. Mol. Biol. Rev., December 1, 2001; 65(4): 497 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hajjaj, P. Niederberger, and P. Duboc Lovastatin Biosynthesis by Aspergillus terreus in a Chemically Defined Medium Appl. Envir. Microbiol., June 1, 2001; 67(6): 2596 - 2602. [Abstract] [Full Text] |
||||
![]() |
M. Orejas, A. P. MacCabe, J. A. Pérez-González, S. Kumar, and D. Ramón The Wide-Domain Carbon Catabolite Repressor CreA Indirectly Controls Expression of the Aspergillus nidulans xlnB Gene, Encoding the Acidic Endo-{beta}-(1,4)-Xylanase X24 J. Bacteriol., March 1, 2001; 183(5): 1517 - 1523. [Abstract] [Full Text] |
||||
![]() |
J. A. Fraser, M. A. Davis, and M. J. Hynes The Formamidase Gene of Aspergillus nidulans: Regulation by Nitrogen Metabolite Repression and Transcriptional Interference by an Overlapping Upstream Gene Genetics, January 1, 2001; 157(1): 119 - 131. [Abstract] [Full Text] |
||||
![]() |
M. Flipphi, M. Mathieu, I. Cirpus, C. Panozzo, and B. Felenbok Regulation of the Aldehyde Dehydrogenase Gene (aldA) and Its Role in the Control of the Coinducer Level Necessary for Induction of the Ethanol Utilization Pathway in Aspergillus nidulans J. Biol. Chem., March 2, 2001; 276(10): 6950 - 6958. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||